These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 29944902)

  • 1. Managing nicotine without smoke to save lives now: Evidence for harm minimization.
    Abrams DB; Glasser AM; Villanti AC; Pearson JL; Rose S; Niaura RS
    Prev Med; 2018 Dec; 117():88-97. PubMed ID: 29944902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Harm Minimization and Tobacco Control: Reframing Societal Views of Nicotine Use to Rapidly Save Lives.
    Abrams DB; Glasser AM; Pearson JL; Villanti AC; Collins LK; Niaura RS
    Annu Rev Public Health; 2018 Apr; 39():193-213. PubMed ID: 29323611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are we guilty of errors of omission on the potential role of electronic nicotine delivery systems as less harmful substitutes for combusted tobacco use?
    Henningfield JE; Higgins ST; Villanti AC
    Prev Med; 2018 Dec; 117():83-87. PubMed ID: 30261245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Obsolete tobacco control themes can be hazardous to public health: the need for updating views on absolute product risks and harm reduction.
    Kozlowski LT; Abrams DB
    BMC Public Health; 2016 May; 16():432. PubMed ID: 27221096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interventions to reduce harm from continued tobacco use.
    Lindson-Hawley N; Hartmann-Boyce J; Fanshawe TR; Begh R; Farley A; Lancaster T
    Cochrane Database Syst Rev; 2016 Oct; 10(10):CD005231. PubMed ID: 27734465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Re: Disregarding the impact of nicotine on the developing brain when evaluating costs and benefits of noncombustible nicotine products.
    Abrams DB; Glasser AM; Villanti AC; Pearson JL; Rose S; Niaura RS
    Prev Med; 2019 Mar; 120():158-159. PubMed ID: 30738502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reducing the nicotine content of combusted tobacco products sold in New Zealand.
    Donny EC; Walker N; Hatsukami D; Bullen C
    Tob Control; 2017 Mar; 26(e1):e37-e42. PubMed ID: 27672126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of reduced-risk nicotine-delivery products on smoking prevalence and cigarette sales: an observational study.
    Pesola F; Phillips-Waller A; Beard E; Shahab L; Sweanor D; Jarvis M; Hajek P
    Public Health Res (Southampt); 2023 Sep; 11(7):1-39. PubMed ID: 37795840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Public Health Policies on E-Cigarettes.
    Bhalerao A; Sivandzade F; Archie SR; Cucullo L
    Curr Cardiol Rep; 2019 Aug; 21(10):111. PubMed ID: 31463564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Editorial: 5
    Higgins ST
    Prev Med; 2018 Dec; 117():1-4. PubMed ID: 30340697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Smokers' Understandings of Addiction to Nicotine and Tobacco: A Systematic Review and Interpretive Synthesis of Quantitative and Qualitative Research.
    Pfeffer D; Wigginton B; Gartner C; Morphett K
    Nicotine Tob Res; 2018 Aug; 20(9):1038-1046. PubMed ID: 29059355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tobacco harm reduction: the need for new products that can compete with cigarettes.
    Fagerström KO; Bridgman K
    Addict Behav; 2014 Mar; 39(3):507-11. PubMed ID: 24290207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electronic cigarettes for adults with tobacco dependence enrolled in a tobacco treatment program: A pilot study.
    Baldassarri SR; Bernstein SL; Chupp GL; Slade MD; Fucito LM; Toll BA
    Addict Behav; 2018 May; 80():1-5. PubMed ID: 29304395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing modified risk tobacco and nicotine products: Description of the scientific framework and assessment of a closed modular electronic cigarette.
    Murphy J; Gaca M; Lowe F; Minet E; Breheny D; Prasad K; Camacho O; Fearon IM; Liu C; Wright C; McAdam K; Proctor C
    Regul Toxicol Pharmacol; 2017 Nov; 90():342-357. PubMed ID: 28954704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging nicotine delivery products. Implications for public health.
    Benowitz NL
    Ann Am Thorac Soc; 2014 Feb; 11(2):231-5. PubMed ID: 24575992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Australian urban Indigenous smokers' perspectives on nicotine products and tobacco harm reduction.
    Yuke K; Ford P; Foley W; Mutch A; Fitzgerald L; Gartner C
    Drug Alcohol Rev; 2018 Jan; 37(1):87-96. PubMed ID: 28493405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Views and Preferences for Nicotine Products as an Alternative to Smoking: A Focus Group Study of People Living with Mental Disorders.
    Meurk C; Ford P; Sharma R; Fitzgerald L; Gartner C
    Int J Environ Res Public Health; 2016 Nov; 13(11):. PubMed ID: 27886046
    [No Abstract]   [Full Text] [Related]  

  • 18. Smokers' behavioral intentions in response to a low-nicotine cigarette policy.
    Patel M; Cuccia AF; Czaplicki L; Donovan EM; Simard B; Pitzer L; Hair EC; Schillo BA; Vallone DM
    Drug Alcohol Depend; 2019 Dec; 205():107645. PubMed ID: 31704376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beliefs and Characteristics Associated With Believing Nicotine Causes Cancer: A Descriptive Analysis to Inform Corrective Message Content and Priority Audiences.
    Weiger C; Moran MB; Kennedy RD; Limaye R; Cohen J
    Nicotine Tob Res; 2022 Jul; 24(8):1264-1272. PubMed ID: 35385112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. European Union policy on smokeless tobacco: a statement in favour of evidence based regulation for public health.
    Bates C; Fagerström K; Jarvis MJ; Kunze M; McNeill A; Ramström L
    Tob Control; 2003 Dec; 12(4):360-7. PubMed ID: 14660767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.